Market research
IDHC.LSE Integrated Diagnostics Holdings plc
LSE USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 306M
- P/E ratio
- 0.11
- Analyst target
- 0.8211
- Dividend yield
- 0.0%
- Beta
- 0.4
Profile
Company facts
- Exchange
- LSE
- Currency
- USD
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- JE00BLKGSR75
- Market cap
- 306M
- P/E ratio
- 0.11
- Analyst target
- 0.8211
- Dividend yield
- 0.0%
- Beta
- 0.4
About
About Integrated Diagnostics Holdings plc
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalography, electroencephalogram, and electrocardiogram, as well as operates cath lab facilities. It operates in Egypt, Sudan, Nigeria, and the Kingdom of Saudi Arabia. The company was founded in 1979 and is based in Saint Helier, Jersey.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the IDHC.LSE discussion.
5 years, 5 months ago
Integrated Diagnostics Holdings plc is currently in a long term downtrend where the price is trading 34.7% below its 200 day moving average.
From a valuation standpoint, the stock is 98.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.8.
Integrated Diagnostics Holdings plc's total revenue sank by 0.0% to $588M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $137M since the same quarter in the previous year.
Based on the above factors, Integrated Diagnostics Holdings plc gets an overall score of 1/5.